Bio-Techne CorpNASDAQ:TECH
- LAST PRICE77.4300
- TODAY'S CHANGE (%)-0.7400 (-0.9467%)
- Bid / Lots76.3000/ 1
- Ask / Lots78.5700/ 1
- Open / Previous Close77.9800 / 78.1700
- Day Range
- 52 Week Range
- Volume714,087
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TECH |
|---|---|---|
| 09:32 ET | 7304 | 77.98 |
| 09:34 ET | 100 | 77.965 |
| 09:36 ET | 100 | 77.965 |
| 09:38 ET | 1999 | 77.55 |
| 09:39 ET | 100 | 77.51 |
| 09:41 ET | 900 | 77.43 |
| 09:43 ET | 2700 | 77.54 |
| 09:45 ET | 100 | 77.435 |
| 09:48 ET | 100 | 77.56 |
| 09:50 ET | 3313 | 77.825 |
| 09:52 ET | 1550 | 77.905 |
| 09:54 ET | 2872 | 77.96 |
| 09:56 ET | 5395 | 78.08 |
| 09:57 ET | 500 | 77.995 |
| 09:59 ET | 200 | 78.005 |
| 10:01 ET | 940 | 77.825 |
| 10:03 ET | 599 | 77.79 |
| 10:06 ET | 6131 | 77.96 |
| 10:08 ET | 400 | 77.725 |
| 10:10 ET | 300 | 77.835 |
| 10:12 ET | 350 | 77.81 |
| 10:14 ET | 9275 | 77.94 |
| 10:15 ET | 200 | 77.78 |
| 10:17 ET | 300 | 77.57 |
| 10:21 ET | 100 | 77.53 |
| 10:24 ET | 200 | 77.52 |
| 10:26 ET | 1731 | 77.45 |
| 10:28 ET | 400 | 77.46 |
| 10:30 ET | 1100 | 77.62 |
| 10:32 ET | 755 | 77.645 |
| 10:33 ET | 100 | 77.785 |
| 10:35 ET | 200 | 77.77 |
| 10:42 ET | 300 | 77.83 |
| 10:44 ET | 2294 | 77.98 |
| 10:46 ET | 100 | 77.9 |
| 10:48 ET | 100 | 77.97 |
| 10:50 ET | 100 | 77.97 |
| 10:51 ET | 13185 | 78.14 |
| 10:53 ET | 200 | 78.02 |
| 10:57 ET | 1010 | 78.025 |
| 11:00 ET | 5746 | 78.18 |
| 11:02 ET | 100 | 78.195 |
| 11:04 ET | 300 | 78.19 |
| 11:06 ET | 2250 | 78.3 |
| 11:08 ET | 3549 | 78.31 |
| 11:09 ET | 11610 | 78.18 |
| 11:11 ET | 200 | 78.09 |
| 11:13 ET | 100 | 78.14 |
| 11:15 ET | 100 | 77.99 |
| 11:18 ET | 400 | 78.085 |
| 11:20 ET | 2439 | 78.22 |
| 11:22 ET | 2528 | 78.35 |
| 11:24 ET | 300 | 78.11 |
| 11:26 ET | 200 | 78.1 |
| 11:29 ET | 3201 | 78.177 |
| 11:31 ET | 735 | 78.18 |
| 11:33 ET | 500 | 78.055 |
| 11:36 ET | 400 | 78.12 |
| 11:38 ET | 700 | 78.19 |
| 11:40 ET | 1568 | 78.22 |
| 11:42 ET | 1126 | 78.22 |
| 11:44 ET | 2424 | 78.22 |
| 11:45 ET | 8300 | 78.3 |
| 11:47 ET | 2500 | 78.29 |
| 11:49 ET | 400 | 78.25 |
| 11:51 ET | 3200 | 78.215 |
| 11:54 ET | 5264 | 78.23 |
| 11:56 ET | 302 | 78.195 |
| 11:58 ET | 2578 | 78.24 |
| 12:00 ET | 100 | 78.2 |
| 12:02 ET | 879 | 78.17 |
| 12:05 ET | 200 | 78.155 |
| 12:07 ET | 100 | 78.11 |
| 12:09 ET | 600 | 78.205 |
| 12:12 ET | 100 | 78.205 |
| 12:16 ET | 1098 | 78.2338 |
| 12:18 ET | 500 | 78.175 |
| 12:20 ET | 300 | 78.07 |
| 12:21 ET | 100 | 78 |
| 12:23 ET | 100 | 78.05 |
| 12:25 ET | 1050 | 77.97 |
| 12:27 ET | 1600 | 78.11 |
| 12:30 ET | 543 | 78.14 |
| 12:32 ET | 2799 | 78.11 |
| 12:34 ET | 4906 | 78.005 |
| 12:36 ET | 4784 | 77.91 |
| 12:38 ET | 300 | 77.8 |
| 12:39 ET | 100 | 77.74 |
| 12:43 ET | 200 | 77.795 |
| 12:45 ET | 9326 | 78.01 |
| 12:48 ET | 900 | 77.97 |
| 12:50 ET | 200 | 77.945 |
| 12:52 ET | 370 | 77.915 |
| 12:54 ET | 100 | 77.925 |
| 12:56 ET | 200 | 77.925 |
| 12:57 ET | 456 | 77.935 |
| 12:59 ET | 200 | 77.935 |
| 01:01 ET | 1650 | 78.06 |
| 01:03 ET | 1287 | 78.06 |
| 01:06 ET | 219 | 78.06 |
| 01:08 ET | 1900 | 78.02 |
| 01:10 ET | 658 | 77.95 |
| 01:12 ET | 700 | 78 |
| 01:14 ET | 754 | 77.905 |
| 01:15 ET | 108 | 77.905 |
| 01:17 ET | 1334 | 78.02 |
| 01:21 ET | 1000 | 78.08 |
| 01:24 ET | 936 | 78.14 |
| 01:30 ET | 1500 | 78.18 |
| 01:32 ET | 2509 | 78.03 |
| 01:35 ET | 2063 | 78.04 |
| 01:37 ET | 939 | 78.045 |
| 01:39 ET | 500 | 78.145 |
| 01:42 ET | 2561 | 78.1 |
| 01:46 ET | 1689 | 78.1195 |
| 01:48 ET | 1400 | 78.1695 |
| 01:50 ET | 2968 | 78.205 |
| 01:51 ET | 5452 | 78.25 |
| 01:53 ET | 3397 | 78.27 |
| 01:55 ET | 1656 | 78.37 |
| 02:00 ET | 300 | 78.275 |
| 02:02 ET | 300 | 78.25 |
| 02:04 ET | 100 | 78.19 |
| 02:06 ET | 400 | 78.205 |
| 02:08 ET | 100 | 78.21 |
| 02:09 ET | 300 | 78.16 |
| 02:11 ET | 430 | 78.18 |
| 02:15 ET | 1650 | 78.16 |
| 02:18 ET | 100 | 78.16 |
| 02:20 ET | 105 | 78.13 |
| 02:22 ET | 200 | 78.08 |
| 02:24 ET | 663 | 78.0075 |
| 02:26 ET | 986 | 77.9 |
| 02:27 ET | 1001 | 78.09 |
| 02:29 ET | 2560 | 78.05 |
| 02:31 ET | 221 | 78.0106 |
| 02:33 ET | 200 | 78.04 |
| 02:36 ET | 3484 | 78 |
| 02:38 ET | 1000 | 77.965 |
| 02:40 ET | 400 | 77.96 |
| 02:42 ET | 10190 | 78.005 |
| 02:44 ET | 8981 | 78.025 |
| 02:45 ET | 4777 | 78 |
| 02:47 ET | 550 | 78.0175 |
| 02:49 ET | 16842 | 78.025 |
| 02:51 ET | 2244 | 78.025 |
| 02:54 ET | 981 | 77.97 |
| 02:56 ET | 12204 | 77.98 |
| 02:58 ET | 5976 | 77.73 |
| 03:00 ET | 885 | 77.735 |
| 03:02 ET | 200 | 77.74 |
| 03:03 ET | 669 | 77.67 |
| 03:05 ET | 300 | 77.67 |
| 03:07 ET | 451 | 77.68 |
| 03:09 ET | 300 | 77.64 |
| 03:12 ET | 400 | 77.66 |
| 03:16 ET | 500 | 77.67 |
| 03:18 ET | 500 | 77.635 |
| 03:20 ET | 912 | 77.56 |
| 03:21 ET | 400 | 77.56 |
| 03:23 ET | 1100 | 77.54 |
| 03:25 ET | 422 | 77.525 |
| 03:27 ET | 1600 | 77.53 |
| 03:30 ET | 368 | 77.54 |
| 03:32 ET | 500 | 77.49 |
| 03:34 ET | 800 | 77.445 |
| 03:36 ET | 6523 | 77.4 |
| 03:38 ET | 1133 | 77.455 |
| 03:39 ET | 700 | 77.495 |
| 03:43 ET | 1388 | 77.445 |
| 03:45 ET | 500 | 77.37 |
| 03:48 ET | 2574 | 77.36 |
| 03:50 ET | 2016 | 77.42 |
| 03:52 ET | 2032 | 77.44 |
| 03:54 ET | 2706 | 77.585 |
| 03:56 ET | 12717 | 77.435 |
| 03:57 ET | 9082 | 77.47 |
| 03:59 ET | 171696 | 77.43 |
Sep 26, 2024
LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH, from 7:00AM ET on Thursday Sep 26, 2024 by Dow Jones
7:00AM ET on Thursday Sep 26, 2024 by Dow Jones
Sep 24, 2024
BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING, from 7:00AM ET on Tuesday Sep 24, 2024 by Dow Jones
7:00AM ET on Tuesday Sep 24, 2024 by Dow Jones
Sep 18, 2024
ScaleReady announces a G-Rex(R) Grant has been awarded to ImmunoScape, from 7:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
7:00AM ET on Wednesday Sep 18, 2024 by Dow JonesBIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT, from 7:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
7:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 17, 2024
ScaleReady announces a G-Rex(R) Grant has been awarded to Verismo Therapeutics, from 7:00AM ET on Tuesday Sep 17, 2024 by Dow Jones
7:00AM ET on Tuesday Sep 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Bio-Techne Corp | 12.4B | 74.0x | +11.13% |
Sarepta Therapeutics Inc | 11.7B | 294.0x | --- |
Neurocrine Biosciences Inc | 11.5B | 34.4x | +62.04% |
Insmed Inc | 12.5B | -13.5x | --- |
Medpace Holdings Inc | 10.3B | 31.7x | +35.10% |
Halozyme Therapeutics Inc | 7.2B | 22.5x | --- |
Company Information
Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.
Contact Information
- Headquarters
- 614 MCKINLEY PL N EMINNEAPOLIS, MN, United States 55413
- Phone
- 612-379-8854
- Fax
- 612-656-4400
Executives
- Independent Chairman of the Board
- Robert Baumgartner
- President, Chief Executive Officer, Chief Operating Officer, Director
- Kim Kelderman
- Chief Financial Officer, Executive Vice President - Finance
- James Hippel
- President - Protein Sciences
- William Geist
- President - Diagnostics and Genomics Segment
- Matthew Mcmanus
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.4B |
|---|---|
Revenue (TTM) | $1.2B |
Shares Outstanding | 158.6M |
Dividend Yield | 0.41% |
Annual Dividend Rate | 0.3200 USD |
Ex-Dividend Date | 08-19-24 |
Pay Date | 08-30-24 |
Beta | 1.27 |
EPS | $1.05 |
Book Value | $13.08 |
P/E Ratio | 74.0x |
Price/Sales (TTM) | 10.7 |
Price/Cash Flow (TTM) | 44.3x |
Operating Margin | 17.83% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
